COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2025

Nov 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2025-11-12

Reporting Person: Fallon John A. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-12	Common Stock	M	15000	$16.49	Acquired	79634	Direct
2025-11-12	Common Stock	M	19853	$9.33	Acquired	99487	Direct
2025-11-12	Common Stock	S	34853	$47.2136	Disposed	64634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-11-12	Stock Option (Right to Purchase)	$16.49	M	15000	Disposed	2026-06-09	Common Stock (15000)	Direct
2025-11-12	Stock Option (Right to Purchase)	$9.33	M	19853	Disposed	2027-05-24	Common Stock (19853)	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.805 to $47.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The option is fully vested and exercisable.